Farid Abdul Hadi - Astellas Pharma Medical Affairs

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 9 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

A retrospective database analysis of anticholinergic burden among older patients with and without overactive bladder in South Korea

Kyu-Sung Lee,Juhee Cho,Hyejeong Park,Danbee Kang,Kwang Jin Ko,Chee Yoong Foo,Matthias Stoelzel,Farid Abdul Hadi,Soyoung Kim

crossref（2024）

引用0浏览0引用

Treatment Patterns with Mirabegron and Antimuscarinics for Overactive Bladder: A Prospective, Registry Study in Taiwan and South Korea (FAITH)

Seung-June Oh,Sung Tae Cho,Hann-Chorng Kuo,Eric Chieh-Lung Chou, Yu-Chao Hsu,Kyu-Sung Lee,Farid Hadi,Yi Song,Budiwan Sumarsono

ADVANCES IN THERAPYno. 4 (2024): 1652-1671

引用0浏览0WOS引用

Safety and Efficacy of an Α1 -Blocker Plus Mirabegron Compared with an Α1 -Blocker Plus Antimuscarinic in Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia and Overactive Bladder: A Systematic Review and Network Meta-Analysis

Sender Herschorn,Tufan Tarcan,Yuan-Hong Jiang,Eric Chung,Farid Abdul Hadi,Achim Steup,Budiwan Sumarsono

Neurourology and urodynamicsno. 3 (2024): 604-619

引用0浏览0WOS引用

Open-label, randomized, post-authorization study of mirabegron in Chinese participants with overactive bladder

Zhipeng Zhang,Deyi Luo,Zhong Chen,Peng Zhang, Ganping Zhong,Keji Xie, Zhuoqun Xu,Xudong Li,Jianye Wang, Yingfan Yang,Farid Abdul Hadi, Arianne Schild

Asian Journal of Urology (2024)

引用0浏览0引用

A Treatment Prediction Strategy for Overactive Bladder Using a Machine Learning Algorithm That Utilized Data from the FAITH Study

Farid Hadi,Budiwan Sumarsono,Kyu-Sung Lee,Seung-June Oh,Sung Tae Cho,Yu-Chao Hsu,Paul Rasner, Cerys Jenkins, Harry Fisher

Continence (2022): 100366-100366

引用2浏览0WOS引用

Mirabegron Has Longer Treatment Persistence Than Antimuscarinics: Real‐world Data from a Korean National Cohort Database

Kyu-Sung Lee,Hyejeong Park,Danbee Kang,Hye J. Byun,Chee Y. Foo,Farid A. Hadi,Soyoung Kim,Juhee Cho

Neurourology and Urodynamics（2021）

引用4浏览0WOS引用

Single‐dose Intravenous Iron in Southeast Asian Heart Failure Patients: A Pilot Randomized Placebo‐controlled Study (PRACTICE‐ASIA‐HF)

Tee Joo Yeo,Poh Shuan Daniel Yeo,Farid Abdul Hadi,Timothy Cushway,Kim Yee Lee, Fang, Anne Ching, Ruili Li,Seet Yoong Loh,Shir Lynn Lim,Raymond Ching-Chiew Wong,Bee Choo Tai,Arthur Mark Richards,Carolyn S. P. Lam

ESC heart failure（2018）

引用34浏览0WOS引用

Rationale and design of a pilot randomized controlled trial to assess the role of intravenous ferric carboxymaltose in Asian patients with heart failure (PRACTICE-ASIA-HF)

Tee Joo Yeo,Poh Shuan Daniel Yeo,Farid Abdul Hadi,Timothy Cushway,Kim Yee Lee,Bee Choo Tai,Carolyn S P Lam

ESC heart failure（2016）

引用9浏览0WOS引用

Health Economic Evaluation Comparing Iv Iron Ferric Carboxymaltose, Iron Sucrose and Blood Transfusion for Treatment of Patients with Iron Deficiency Anemia (ida) in Singapore

D. E. H. Ong,F. Hadi, V Stevens

Value in Health（2014）

引用3浏览0WOS引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn